Matches in Wikidata for { <http://www.wikidata.org/entity/Q34779671> ?p ?o ?g. }
- Q34779671 description "2014 nî lūn-bûn" @default.
- Q34779671 description "2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած" @default.
- Q34779671 description "2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված" @default.
- Q34779671 description "2014年の論文" @default.
- Q34779671 description "2014年論文" @default.
- Q34779671 description "2014年論文" @default.
- Q34779671 description "2014年論文" @default.
- Q34779671 description "2014年論文" @default.
- Q34779671 description "2014年論文" @default.
- Q34779671 description "2014年论文" @default.
- Q34779671 description "2014年论文" @default.
- Q34779671 description "2014年论文" @default.
- Q34779671 description "2014年论文" @default.
- Q34779671 description "2014年论文" @default.
- Q34779671 description "2014年论文" @default.
- Q34779671 description "2014년 논문" @default.
- Q34779671 description "article científic" @default.
- Q34779671 description "article scientific" @default.
- Q34779671 description "article scientifique (publié 2014)" @default.
- Q34779671 description "articol științific" @default.
- Q34779671 description "articolo scientifico" @default.
- Q34779671 description "artigo científico (publicado na 2014)" @default.
- Q34779671 description "artigo científico (publicado na 2014)" @default.
- Q34779671 description "artigo científico" @default.
- Q34779671 description "artikull shkencor" @default.
- Q34779671 description "artikulong pang-agham" @default.
- Q34779671 description "artykuł naukowy" @default.
- Q34779671 description "artículo científico publicado en 2014" @default.
- Q34779671 description "artículu científicu espublizáu en 2014" @default.
- Q34779671 description "bilimsel makale" @default.
- Q34779671 description "bài báo khoa học" @default.
- Q34779671 description "mokslinis straipsnis" @default.
- Q34779671 description "naučni članak" @default.
- Q34779671 description "scienca artikolo" @default.
- Q34779671 description "scientific article" @default.
- Q34779671 description "teaduslik artikkel" @default.
- Q34779671 description "tieteellinen artikkeli" @default.
- Q34779671 description "tudományos cikk" @default.
- Q34779671 description "vedecký článok" @default.
- Q34779671 description "vetenskaplig artikel" @default.
- Q34779671 description "videnskabelig artikel (udgivet 2014)" @default.
- Q34779671 description "vitenskapelig artikkel" @default.
- Q34779671 description "vitskapeleg artikkel" @default.
- Q34779671 description "vědecký článek" @default.
- Q34779671 description "wetenschappelijk artikel" @default.
- Q34779671 description "wissenschaftlicher Artikel" @default.
- Q34779671 description "επιστημονικό άρθρο" @default.
- Q34779671 description "мақолаи илмӣ" @default.
- Q34779671 description "мақолаи илмӣ" @default.
- Q34779671 description "наукова стаття, опублікована в грудні 2014" @default.
- Q34779671 description "научна статия" @default.
- Q34779671 description "научная статья" @default.
- Q34779671 description "научни чланак" @default.
- Q34779671 description "научни чланак" @default.
- Q34779671 description "מאמר מדעי" @default.
- Q34779671 description "سائنسی مضمون" @default.
- Q34779671 description "مقالة علمية" @default.
- Q34779671 description "مقالهٔ علمی" @default.
- Q34779671 description "২০১৪-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q34779671 description "บทความทางวิทยาศาสตร์" @default.
- Q34779671 description "სამეცნიერო სტატია" @default.
- Q34779671 name "Safety and tolerability of docetaxel, cyclophosphamide, and trastuzumab compared to standard trastuzumab-based chemotherapy regimens for early-stage human epidermal growth factor receptor 2-positive breast cancer" @default.
- Q34779671 name "Safety and tolerability of docetaxel, cyclophosphamide, and trastuzumab compared to standard trastuzumab-based chemotherapy regimens for early-stage human epidermal growth factor receptor 2-positive breast cancer" @default.
- Q34779671 name "Safety and tolerability of docetaxel, cyclophosphamide, and trastuzumab compared to standard trastuzumab-based chemotherapy regimens for early-stage human epidermal growth factor receptor 2-positive breast cancer" @default.
- Q34779671 type Item @default.
- Q34779671 label "Safety and tolerability of docetaxel, cyclophosphamide, and trastuzumab compared to standard trastuzumab-based chemotherapy regimens for early-stage human epidermal growth factor receptor 2-positive breast cancer" @default.
- Q34779671 label "Safety and tolerability of docetaxel, cyclophosphamide, and trastuzumab compared to standard trastuzumab-based chemotherapy regimens for early-stage human epidermal growth factor receptor 2-positive breast cancer" @default.
- Q34779671 label "Safety and tolerability of docetaxel, cyclophosphamide, and trastuzumab compared to standard trastuzumab-based chemotherapy regimens for early-stage human epidermal growth factor receptor 2-positive breast cancer" @default.
- Q34779671 prefLabel "Safety and tolerability of docetaxel, cyclophosphamide, and trastuzumab compared to standard trastuzumab-based chemotherapy regimens for early-stage human epidermal growth factor receptor 2-positive breast cancer" @default.
- Q34779671 prefLabel "Safety and tolerability of docetaxel, cyclophosphamide, and trastuzumab compared to standard trastuzumab-based chemotherapy regimens for early-stage human epidermal growth factor receptor 2-positive breast cancer" @default.
- Q34779671 prefLabel "Safety and tolerability of docetaxel, cyclophosphamide, and trastuzumab compared to standard trastuzumab-based chemotherapy regimens for early-stage human epidermal growth factor receptor 2-positive breast cancer" @default.
- Q34779671 P1433 Q34779671-48112BA1-79CA-41FE-8A5F-322404F10054 @default.
- Q34779671 P1476 Q34779671-6C2B6F22-27A7-468B-9EB3-92397F93BFAD @default.
- Q34779671 P2093 Q34779671-0E276CC0-AE05-423B-B7F8-DB72C78AC31F @default.
- Q34779671 P2093 Q34779671-74E6ADCD-DBFC-405A-839C-7A877E4928CE @default.
- Q34779671 P2093 Q34779671-89C529A3-2E76-4F92-ACB1-7AD3285953C1 @default.
- Q34779671 P2093 Q34779671-C09BABDD-E38A-4B4E-BA7F-59521359671D @default.
- Q34779671 P2093 Q34779671-FEB8A387-D4F8-404E-911D-917A9A02C09D @default.
- Q34779671 P275 Q34779671-8f9ecea1-facd-4dc4-86a8-f7b6d875148a @default.
- Q34779671 P2860 Q34779671-05F4AFD3-74D9-438F-B882-1C1B279CFD4D @default.
- Q34779671 P2860 Q34779671-1ADE4D77-D9F0-4602-9C5E-C6C5AAFD63D6 @default.
- Q34779671 P2860 Q34779671-208ECEF4-354F-4FD1-90E1-5CB790D6704C @default.
- Q34779671 P2860 Q34779671-2C308D94-A49A-4937-AC25-E8E2B1A1CDFD @default.
- Q34779671 P2860 Q34779671-39616C28-73EF-49C1-B750-EB0EC3C15C00 @default.
- Q34779671 P2860 Q34779671-3E201E61-95E0-43E1-A5EA-C9F4E8B2B170 @default.
- Q34779671 P2860 Q34779671-40DF3C7F-436D-4870-A293-96629F179152 @default.
- Q34779671 P2860 Q34779671-6361EC60-4357-4D8D-8B09-F9F574323310 @default.
- Q34779671 P2860 Q34779671-6887708D-DA03-4F90-A1E6-868EBF944A66 @default.
- Q34779671 P2860 Q34779671-6C44C962-ACA4-408B-8378-8C2E0F4E1564 @default.
- Q34779671 P2860 Q34779671-78A1550D-AD19-495D-90CE-C96D8C7E26BA @default.
- Q34779671 P2860 Q34779671-7D411C59-1B7C-42CF-AEC6-15B05C53D9B4 @default.
- Q34779671 P2860 Q34779671-9CE48FAC-4D56-43A9-AF65-B877EFBDD2FC @default.
- Q34779671 P2860 Q34779671-A234FEBC-6702-4FFA-B0EC-B0FBB8F8D45F @default.
- Q34779671 P2860 Q34779671-A37B6769-5F7D-4051-8478-891CCE6369AB @default.
- Q34779671 P2860 Q34779671-AA4D7950-3914-4707-95F1-27CCECCD0E1D @default.
- Q34779671 P2860 Q34779671-AB5E6E09-56F0-4AC0-A9A0-3B7EE1D652A2 @default.
- Q34779671 P2860 Q34779671-C86C3B32-7456-44BB-85F8-F6F69747636F @default.
- Q34779671 P2860 Q34779671-CA7700A8-3F79-48AE-85F1-D5666664741F @default.
- Q34779671 P2860 Q34779671-CBD37C8F-BFF8-41A5-8692-1A22A6011066 @default.
- Q34779671 P2860 Q34779671-CF71541C-03E8-47E4-AD45-96902B89C621 @default.